Terminal › Stocks › XXII

22nd Century Group, Inc. (XXII) Stock

Consumer Defensive · Tobacco · US

$4.65 -15.55%

Last updated Jun 18, 2026 23:59 UTC

XXII Key Statistics

Market Cap$1.60M

P/E (TTM)-0.02

P/S (TTM)0.18

P/B (TTM)0.13

Revenue (TTM)$8.88M

EPS (TTM)$-231.12

Dividend Yield—

ROE (TTM)-25.03%

Net Margin-44.90%

Gross Margin-36.66%

52W High$15.20

52W Low$0.27

Analyst ViewBuy

Price Target$1,237.50

Employees56

Volume73,988

About 22nd Century Group, Inc.

22nd Century Group, Inc. is an agricultural biotechnology firm dedicated to mitigating the risks associated with tobacco use and improving health and wellness through advanced plant science. The company serves the life science and consumer product sectors. Its innovations include ultra-low nicotine tobacco and cigarette offerings, marketed under the VLN King and VLN Menthol King brands, as well as SPECTRUM research cigarettes used in independent scientific investigations. Furthermore, 22nd Century Group collaborates with Keygene N.V. to cultivate hemp and cannabis plants engineered for superior cannabinoid content and enhanced agricultural characteristics, intended for medical, therapeutic, farming, and other applications. Established in 1998, the company is based in Buffalo, New York.

CEO: Lawrence D. Firestone. Company website

See XXII live in QFI Terminal

Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.

Open XXII in Terminal See plans

More Consumer Defensive stocks

CCU Compañía Cervecerías Unidas S.A. WMT Walmart Inc. COST Costco Wholesale Corporation WYHG Wing Yip Food Holdings Group Limited American Depositary Shares KR The Kroger Co. TGT Target Corporation PEP PepsiCo, Inc. ABEV Ambev S.A.